Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.
In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™for all indicationsmatching the reference product ...
The Bismarck Tribune10h
Judge extends temporary block to cuts in National Institutes of Health research funding
A federal judge on Friday again blocked the Trump administration's cuts in medical research funding that many scientists say ...
Independent Record19h
GOP Senators push through budget; Canada tops US in 4 Nations final | Hot off the Wire
Get a recap of recent financial, health and general interest stories through this special edition of our Hot off the Wire ...